Acyclovir - 52959-517-35 - (Acyclovir)

Alphabetical Index


Drug Information of Acyclovir

Product NDC: 52959-517
Proprietary Name: Acyclovir
Non Proprietary Name: Acyclovir
Active Ingredient(s): 200    mg/1 & nbsp;   Acyclovir
Administration Route(s): ORAL
Dosage Form(s): CAPSULE
Coding System: National Drug Codes(NDC)

Labeler Information of Acyclovir

Product NDC: 52959-517
Labeler Name: H.J. Harkins Company, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA074578
Marketing Category: ANDA
Start Marketing Date: 20110527

Package Information of Acyclovir

Package NDC: 52959-517-35
Package Description: 35 CAPSULE in 1 BOTTLE (52959-517-35)

NDC Information of Acyclovir

NDC Code 52959-517-35
Proprietary Name Acyclovir
Package Description 35 CAPSULE in 1 BOTTLE (52959-517-35)
Product NDC 52959-517
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Acyclovir
Dosage Form Name CAPSULE
Route Name ORAL
Start Marketing Date 20110527
Marketing Category Name ANDA
Labeler Name H.J. Harkins Company, Inc.
Substance Name ACYCLOVIR
Strength Number 200
Strength Unit mg/1
Pharmaceutical Classes DNA Polymerase Inhibitors [MoA],Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient]

Complete Information of Acyclovir


General Information